IDEXX reports second quarter revenue growth of 10%, raises full year outlook
The company raised its 2026 revenue and EPS guidance ranges after second quarter results driven by CAG Diagnostics gains and IDEXX inVue Dx placements.
SEC filing
Latest
1 story